The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Microglia degrade Alzheimer’s amyloid-beta deposits extracellularly via digestive exophagy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LE is used by microglia to release cytokines, enzymes, and cargo into the extracellular space.
“LE is used by microglia to release cytokines, enzymes, and cargo into the extracellular space (Dou et al. 2012; Jacquet et al. 2024; Kreher et al. 2021).”
From The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia (2025) · cites this paper as Jacquet et al. 2024
The Results sections on lysosomal synapses and Aβ fibril secretion report microglial lysosomal exocytosis of contents into extracellular compartments, including enzymes and previously endocytosed Aβ cargo. They do not report cytokine release by this mechanism; the Limitations of the study mentions cytokines only as components absent from the model aggregates. No page numbers are available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Donanemab in Early Alzheimer’s Disease
Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728
Spangenberg, E., Severson, P. L., Hohsfield, L. A., Crapser, J., Zhang, J., Burton, E. A., Zhang, Y., Spevak, W., Lin, J., Phan, N. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11674-z · Cited by 939
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840
Lee, J.-H., Yang, D.-S., Goulbourne, C. N., Im, E., Stavrides, P., Pensalfini, A., Chan, H., Bouchet-Marquis, C., Bleiwas, C., Berg, M. J., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01084-8 · Cited by 638
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 567
Microglia use TAM receptors to detect and engulf amyloid β plaques
Huang, Y., Happonen, K. E., Burrola, P. G., O’Connor, C., Hah, N., Huang, L., Nimmerjahn, A., & Lemke, G. (2021) · Nature Immunology · doi:10.1038/s41590-021-00913-5 · Cited by 483
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468
Doens, D., & Fernández, P. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-48 · Cited by 348
The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer’s disease
Hopp, S. C., Lin, Y., Oakley, D., Roe, A. D., DeVos, S. L., Hanlon, D., & Hyman, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1309-z · Cited by 286
Activation of Microglia Acidifies Lysosomes and Leads to Degradation of Alzheimer Amyloid Fibrils
Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Lobel, P., & Maxfield, F. R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0975 · Cited by 271
Self-citationBaik, S. H., Kang, S., Son, S. M., & Mook-Jung, I. (2016) · Glia · doi:10.1002/glia.23074 · Cited by 234
Wilcock, D. M., Munireddy, S. K., Rosenthal, A., Ugen, K. E., Gordon, M. N., & Morgan, D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.015 · Cited by 202
Casali, B. T., MacPherson, K. P., Reed-Geaghan, E. G., & Landreth, G. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104956 · Cited by 186
The endocytic pathway in microglia during health, aging and Alzheimer’s disease
Solé-Domènech, S., Cruz, D. L., Capetillo-Zarate, E., & Maxfield, F. R. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.002 · Cited by 133
Self-citationMicroglia-Mediated Neuroprotection, TREM2, and Alzheimer’s Disease: Evidence From Optical Imaging
Condello, C., Yuan, P., & Grutzendler, J. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.007 · Cited by 131
Sahasrabuddhe, V., & Ghosh, H. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110252 · Cited by 91
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations
Cadiz, M. P., Gibson, K. A., Todd, K. T., Nascari, D. G., Massa, N., Lilley, M. T., Olney, K. C., Al-Amin, M. M., Jiang, H., Holtzman, D. M., et al. (2024) · Journal of Experimental Medicine · doi:10.1084/jem.20231363 · Cited by 55
Flagged first, then by citations
Research works printed but not linked: 68
- Selkoe, 2016, The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol. Med., 8, 595, 10.15252/emmm.201606210 · DOI · Paper page
- Diaz-Aparicio, 2016, Clearing the corpses: regulatory mechanisms, novel tools, and therapeutic potential of harnessing microglial phagocytosis in the diseased brain, Neural Regen. Res., 11, 1533, 10.4103/1673-5374.193220 · DOI
- Li, 2018, Microglia and macrophages in brain homeostasis and disease, Nat. Rev. Immunol., 18, 225, 10.1038/nri.2017.125 · DOI · Paper page
- Monsorno, 2023, Loss of microglial MCT4 leads to defective synaptic pruning and anxiety-like behavior in mice, Nat. Commun., 14, 5749, 10.1038/s41467-023-41502-4 · DOI
- Efthymiou, 2017, Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk, Mol. Neurodegener., 12, 43, 10.1186/s13024-017-0184-x · DOI · Paper page
- Condello, 2015, Microglia constitute a barrier that prevents neurotoxic protofibrillar Abeta42 hotspots around plaques, Nat. Commun., 6, 6176, 10.1038/ncomms7176 · DOI · Paper page
- Koffie, 2009, Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques, Proc. Natl. Acad. Sci. USA, 106, 4012, 10.1073/pnas.0811698106 · DOI · Paper page
- Katzmarski, 2020, Abeta oligomers trigger and accelerate Abeta seeding, Brain Pathol., 30, 36, 10.1111/bpa.12734 · DOI
- Norambuena, 2022, SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-beta oligomers, Neurobiol. Dis., 169, 10.1016/j.nbd.2022.105737 · DOI
- Norambuena, 2018, A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-beta oligomers, EMBO J., 37, 10.15252/embj.2018100241 · DOI · Paper page
- Parodi-Rullán, 2020, Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis, Aging Cell, 19, 10.1111/acel.13258 · DOI
- Zhao, 2017, Microglia limit the expansion of beta-amyloid plaques in a mouse model of Alzheimer's disease, Mol. Neurodegener., 12, 47, 10.1186/s13024-017-0188-6 · DOI · Paper page
- Lacorte, 2022, Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials, J. Alzheimers Dis., 87, 101, 10.3233/JAD-220046 · DOI
- Chung, 1999, Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells, J. Biol. Chem., 274, 32301, 10.1074/jbc.274.45.32301 · DOI · Paper page
- Mandrekar, 2009, Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis, J. Neurosci., 29, 4252, 10.1523/JNEUROSCI.5572-08.2009 · DOI · Paper page
- Paresce, 1996, Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor, Neuron, 17, 553, 10.1016/S0896-6273(00)80187-7 · DOI · Paper page
- Walker, 2020, Abeta Plaques, Free Neuropathol., 1, 1
- Haka, 2009, Macrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins, Mol. Biol. Cell, 20, 4932, 10.1091/mbc.e09-07-0559 · DOI
- Singh, 2016, Degradation of aggregated LDL occurs in complex extracellular sub-compartments of the lysosomal synapse, J. Cell Sci., 129, 1072, 10.1242/jcs.181743 · DOI
- Singh, 2019, Dynamic Actin Reorganization and Vav/Cdc42-Dependent Actin Polymerization Promote Macrophage Aggregated LDL (Low-Density Lipoprotein) Uptake and Catabolism, Arterioscler. Thromb. Vasc. Biol., 39, 137, 10.1161/ATVBAHA.118.312087 · DOI
- Haka, 2016, Exocytosis of macrophage lysosomes leads to digestion of apoptotic adipocytes and foam cell formation, J. Lipid Res., 57, 980, 10.1194/jlr.M064089 · DOI
- Sobacchi, 2013, Osteopetrosis: genetics, treatment and new insights into osteoclast function, Nat. Rev. Endocrinol., 9, 522, 10.1038/nrendo.2013.137 · DOI · Paper page
- Singh, 2020, TLR4 (Toll-Like Receptor 4)-Dependent Signaling Drives Extracellular Catabolism of LDL (Low-Density Lipoprotein) Aggregates, Arterioscler. Thromb. Vasc. Biol., 40, 86, 10.1161/ATVBAHA.119.313200 · DOI
- Kirschner, 1986, X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation, Proc. Natl. Acad. Sci. USA, 83, 503, 10.1073/pnas.83.2.503 · DOI
- Harada, 2011, CD measurements of beta-amyloid (1-40) and (1-42) in the condensed phase, Biopolymers, 95, 127, 10.1002/bip.21543 · DOI
- Basu, 2014, Insights into binding of cholera toxin to GM1 containing membrane, Langmuir, 30, 15244, 10.1021/la5036618 · DOI
- Huff, 2015, The Airyscan detector from ZEISS: confocal imaging with improved signal-to-noise ratio and super-resolution, Nat. Methods, 12, 10.1038/nmeth.f.388 · DOI
- Mukherjee, 1997, Endocytosis, Physiol. Rev., 77, 759, 10.1152/physrev.1997.77.3.759 · DOI
- Solé-Domènech, 2024, Ratiometric pH Imaging of Macrophage Lysosomes Using the Novel pH-sensitive Dye ApHID, bioRxiv
- Sjöback, 1995, Absorption and fluorescence properties of fluorescein, Spectrochim. Acta Mol. Biomol. Spectrosc., 51, L7, 10.1016/0584-8539(95)01421-P · DOI
- Chaussade, 2007, Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling, Biochem. J., 404, 449, 10.1042/BJ20070003 · DOI
- Zhao, 2005, Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors, Bioorg. Med. Chem. Lett., 15, 905, 10.1016/j.bmcl.2004.12.062 · DOI
- Maxfield, 2020, Digestive exophagy: Phagocyte digestion of objects too large for phagocytosis, Traffic, 21, 6, 10.1111/tra.12712 · DOI
- Henneberry, 1979, Acid phosphatase, Urol. Clin. North Am., 6, 629, 10.1016/S0094-0143(21)01218-0 · DOI
- Jerome, 1998, Lysosomal lipid accumulation from oxidized low density lipoprotein is correlated with hypertrophy of the Golgi apparatus and trans-Golgi network, J. Lipid Res., 39, 1362, 10.1016/S0022-2275(20)32516-5 · DOI
- Forner, 2021, Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease, Sci. Data, 8, 270, 10.1038/s41597-021-01054-y · DOI · Paper page
- St-Pierre, 2022, Investigating Microglial Ultrastructural Alterations and Intimate Relationships with Neuronal Stress, Dystrophy, and Degeneration in Mouse Models of Alzheimer's Disease, Methods Mol. Biol., 2515, 29, 10.1007/978-1-0716-2409-8_3 · DOI · Paper page
- Buchanan, 2022, Oligodendrocyte precursor cells ingest axons in the mouse neocortex, Proc. Natl. Acad. Sci. USA, 119, 10.1073/pnas.2202580119 · DOI
- Bisht, 2016, Correlative Light and Electron Microscopy to Study Microglial Interactions with beta-Amyloid Plaques, J. Vis. Exp., 112
- McClintock, 1982, Lead staining in the Golgi complex, Tissue Cell, 14, 541, 10.1016/0040-8166(82)90046-5 · DOI
- Sole-Domenech, 2018, Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Abeta by multiple endoproteolytic cleavages within the beta-sheet domain, Proc. Natl. Acad. Sci. USA, 115, 1493, 10.1073/pnas.1719808115 · DOI
- Majumdar, 2011, Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes, Mol. Biol. Cell, 22, 1664, 10.1091/mbc.e10-09-0745 · DOI
- d'Errico, 2022, Microglia contribute to the propagation of Abeta into unaffected brain tissue, Nat. Neurosci., 25, 20, 10.1038/s41593-021-00951-0 · DOI · Paper page
- Hornik, 2014, Inflammation induces multinucleation of Microglia via PKC inhibition of cytokinesis, generating highly phagocytic multinucleated giant cells, J. Neurochem., 128, 650, 10.1111/jnc.12477 · DOI
- Maxfield, 2023, The formation and consequences of cholesterol-rich deposits in atherosclerotic lesions, Front. Cardiovasc. Med., 10, 10.3389/fcvm.2023.1148304 · DOI
- Coats, 2017, Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity, Cell Rep., 20, 3149, 10.1016/j.celrep.2017.08.096 · DOI · Paper page
- Maeda, 2016, Real-time intravital imaging of pH variation associated with osteoclast activity, Nat. Chem. Biol., 12, 579, 10.1038/nchembio.2096 · DOI
- Al-Ali, 1982, Brain phagocytes: source of high acid phosphatase activity, Am. J. Pathol., 107, 51
- Li, 1996, Microglia-derived macrophages in early multiple sclerosis plaques, Neuropathol. Appl. Neurobiol., 22, 207, 10.1111/j.1365-2990.1996.tb00896.x · DOI
- Gowrishankar, 2015, Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques, Proc. Natl. Acad. Sci. USA, 112, E3699, 10.1073/pnas.1510329112 · DOI · Paper page
- Wegiel, 1990, The complex of microglial cells and amyloid star in three-dimensional reconstruction, Acta Neuropathol., 81, 116, 10.1007/BF00334499 · DOI
- Stalder, 2001, 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid, Neurobiol. Aging, 22, 427, 10.1016/S0197-4580(01)00209-3 · DOI · Paper page
- d'Errico, 2020, Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer's Disease, Front. Aging Neurosci., 12, 265, 10.3389/fnagi.2020.00265 · DOI
- Asai, 2015, Depletion of microglia and inhibition of exosome synthesis halt tau propagation, Nat. Neurosci., 18, 1584, 10.1038/nn.4132 · DOI · Paper page
- Bassil, 2020, Amyloid-Beta (Abeta) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Abeta Pathology, Neuron, 105, 260, 10.1016/j.neuron.2019.10.010 · DOI
- Im, 2023, Lysosomal dysfunction in Down syndrome and Alzheimer mouse models is caused by v-ATPase inhibition by Tyr(682)-phosphorylated APP betaCTF, Sci. Adv., 9, 10.1126/sciadv.adg1925 · DOI · Paper page
- Miranda, 2018, Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders, Cell Stress, 2, 115, 10.15698/cst2018.05.136 · DOI
- Eckman, 2023, Nascent Abeta42 Fibrillization in Synaptic Endosomes Precedes Plaque Formation in a Mouse Model of Alzheimer's-like beta-Amyloidosis, J. Neurosci., 43, 8812, 10.1523/JNEUROSCI.1318-23.2023 · DOI
- Martinsson, 2022, Abeta/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer's Disease, Front. Aging Neurosci., 14, 10.3389/fnagi.2022.946297 · DOI
- Wang, 2015, TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model, Cell, 160, 1061, 10.1016/j.cell.2015.01.049 · DOI · Paper page
- Zhao, 2018, TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function, Neuron, 97, 1023, 10.1016/j.neuron.2018.01.031 · DOI · Paper page
- Jantti, 2022, Microglial amyloid beta clearance is driven by PIEZO1 channels, J. Neuroinflammation, 19, 147, 10.1186/s12974-022-02486-y · DOI
- Pesti, 2024, Primary microglia cell cultures in translational research: Strengths and limitations, J. Biotechnol., 386, 10, 10.1016/j.jbiotec.2024.03.005 · DOI
- Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019 · DOI · Paper page
- Maxfield, 1982, Weak bases and ionophores rapidly and reversibly raise the pH of endocytic vesicles in cultured mouse fibroblasts, J. Cell Biol., 95, 676, 10.1083/jcb.95.2.676 · DOI
- Milner, 2011, Degenerating processes identified by electron microscopic immunocytochemical methods, Methods Mol. Biol., 793, 23, 10.1007/978-1-61779-328-8_3 · DOI
- Gomori, 1950, An Improved Histochemical Technic for Acid Phosphatase, Stain Technol., 25, 81, 10.3109/10520295009110962 · DOI
- Nahirney, 2021, Brain Ultrastructure: Putting the Pieces Together, Front. Cell Dev. Biol., 9, 10.3389/fcell.2021.629503 · DOI
Cited by
Sorted by citations
Microglial phagocytosis in Alzheimer disease
Brown, G. C., St George-Hyslop, P., Paolicelli, R. C., & Lemke, G. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-025-01162-y · Cited by 36
The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia
Mishra, S., Morshed, N., Sidhu, S. B., Kinoshita, C., Stevens, B., Jayadev, S., & Young, J. E. (2025) · Glia · doi:10.1002/glia.70009 · Cited by 31
Metadata
- Authors
- Jacquet, R. G., González Ibáñez, F., Picard, K., Funes, L., Khakpour, M., Gouras, G. K., Tremblay, M.-È., Maxfield, F. R., & Solé-Domènech, S.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2024-12
- Volume
- 43
- Issue
- 12
- Pages
- 115052
- ISSN
- 2211-1247
- PMC
- PMC11760508
- Cited by
- 42
- References
- 19
- Language
- en
- Licence
- Funders
- National Institutes of Health (R01-HL093324, RF1-AG078244)
- Cure Alzheimer's Fund (CAF-211540-02)
- National Research Council Canada (CRC-2019-00407)
- Swedish Research Council (637-2013-503/D0050301)
- Canada Foundation for Innovation
- Mexico State Government Mexican Council for Science and Technology
- Leon Levy Foundation
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- Canada Research Chairs
- Vanderbilt University Medical Center
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review